For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Emergent Biosolutions Inc’s stock clocked out at $6.94, up 3.12% from its previous closing price of $6.73. In other words, the price has increased by $3.12 from its previous closing price. On the day, 1.62 million shares were traded. EBS stock price reached its highest trading level at $7.02 during the session, while it also had its lowest trading level at $6.54.
Ratios:
To gain a deeper understanding of EBS’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.47 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 3.99. For the most recent quarter (mrq), Quick Ratio is recorded 3.51 and its Current Ratio is at 6.32. In the meantime, Its Debt-to-Equity ratio is 1.22 whereas as Long-Term Debt/Eq ratio is at 1.21.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 30, 2024, initiated with a Buy rating and assigned the stock a target price of $15.
On August 22, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $16.
The Benchmark Company Upgraded its Hold to Buy on March 07, 2024, while the target price for the stock was maintained at $5.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 13 ’25 when PAPA JOSEPH C bought 60,000 shares for $5.83 per share. The transaction valued at 349,800 led to the insider holds 342,500 shares of the business.
Fowler Neal Franklin sold 35,000 shares of EBS for $204,050 on Mar 12 ’25. The Director now owns 101,100 shares after completing the transaction at $5.83 per share. On Mar 12 ’25, another insider, Zoon Kathryn C, who serves as the Director of the company, sold 10,000 shares for $5.73 each. As a result, the insider received 57,300 and left with 44,482 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EBS now has a Market Capitalization of 376687936 and an Enterprise Value of 900288128. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.39 while its Price-to-Book (P/B) ratio in mrq is 0.68. Its current Enterprise Value per Revenue stands at 0.933 whereas that against EBITDA is 14.568.
Stock Price History:
The Beta on a monthly basis for EBS is 2.14, which has changed by 0.38247013 over the last 52 weeks, in comparison to a change of 0.11936104 over the same period for the S&P500. Over the past 52 weeks, EBS has reached a high of $15.10, while it has fallen to a 52-week low of $4.02. The 50-Day Moving Average of the stock is 31.77%, while the 200-Day Moving Average is calculated to be -13.05%.
Shares Statistics:
It appears that EBS traded 1.33M shares on average per day over the past three months and 1821420 shares per day over the past ten days. A total of 54.50M shares are outstanding, with a floating share count of 51.91M. Insiders hold about 4.37% of the company’s shares, while institutions hold 65.64% stake in the company. Shares short for EBS as of 1745971200 were 7754707 with a Short Ratio of 5.81, compared to 1743379200 on 8971117. Therefore, it implies a Short% of Shares Outstanding of 7754707 and a Short% of Float of 14.430000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
